Antibody levels following WI38 rabies vaccine. 1978

V J Cabasso, and R E Louie, and B Lo, and M B Dobkin

WI38 rabies vaccine lots with varying mouse potency ratios were compared in their ability to induce neutralizing antibody in human volunteers. Three vaccination schedules were used: 0, 7 and 14 days; o,7 and 21 days; and 0,28 and 56 days. Regardless of the mouse potency ratio, antibody was barely or not detectable on the 7th day after the first dose of vaccine. After the second dose, however, there was a very good correlation between mouse potency and antibody level attained. Vaccines with potency ratios above 2 gave comparable results, whether the 0, 7, 14 or 0, 28, 56 schedules were used. The lowest potency vaccine, however, have a much better response when given at 0, 7 and 14 days than at 0, 28, and 56 days. Although the vaccine with the greatest potency ratio produced the highest levels of antibody, very adequate responses were obtained in 100% of recipients after three doses of vaccines having a ratio greater than 2, given at 0, 7, 14 or 0, 7, 21 days.

UI MeSH Term Description Entries
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D007158 Immunologic Techniques Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies. Antibody Dissociation,Immunologic Technic,Immunologic Technics,Immunologic Technique,Immunological Technics,Immunological Techniques,Technic, Immunologic,Technics, Immunologic,Technique, Immunologic,Techniques, Immunologic,Antibody Dissociations,Dissociation, Antibody,Dissociations, Antibody,Immunological Technic,Immunological Technique,Technic, Immunological,Technics, Immunological,Technique, Immunological,Techniques, Immunological
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D046508 Culture Techniques Methods of maintaining or growing biological materials in controlled laboratory conditions. These include the cultures of CELLS; TISSUES; organs; or embryo in vitro. Both animal and plant tissues may be cultured by a variety of methods. Cultures may derive from normal or abnormal tissues, and consist of a single cell type or mixed cell types. Culture Technique,Technique, Culture,Techniques, Culture

Related Publications

V J Cabasso, and R E Louie, and B Lo, and M B Dobkin
January 1982, Comparative immunology, microbiology and infectious diseases,
V J Cabasso, and R E Louie, and B Lo, and M B Dobkin
January 2011, Advances in preventive medicine,
V J Cabasso, and R E Louie, and B Lo, and M B Dobkin
October 1989, The Practitioner,
V J Cabasso, and R E Louie, and B Lo, and M B Dobkin
April 2005, Free radical biology & medicine,
V J Cabasso, and R E Louie, and B Lo, and M B Dobkin
January 2020, Tropical doctor,
V J Cabasso, and R E Louie, and B Lo, and M B Dobkin
March 1981, American journal of epidemiology,
V J Cabasso, and R E Louie, and B Lo, and M B Dobkin
February 1985, MMWR. Morbidity and mortality weekly report,
V J Cabasso, and R E Louie, and B Lo, and M B Dobkin
January 1992, Vaccine,
V J Cabasso, and R E Louie, and B Lo, and M B Dobkin
March 1974, Applied microbiology,
V J Cabasso, and R E Louie, and B Lo, and M B Dobkin
January 1987, The American journal of tropical medicine and hygiene,
Copied contents to your clipboard!